Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ADGMNYSEAMERICAN:COHNOTCMKTS:GBCSNASDAQ:RMCO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADGMAdagio Medical$1.19+3.5%$1.07$0.63▼$9.34$18.31M0.09794,203 shs41,453 shsCOHNCohen & Company Inc.$8.04-1.0%$8.04$6.10▼$12.82$15.68M1.259,744 shs5,674 shsGBCSSelectis Health$1.51$2.07$1.12▼$2.50$4.63M-0.422,462 shsN/ARMCORoyalty Management$1.16+0.4%$1.11$0.74▼$1.59$17.28M-0.2530,311 shs11,604 shs20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADGMAdagio Medical+3.48%+0.85%+7.21%-15.00%+118,999,900.00%COHNCohen & Company Inc.-0.99%-9.36%+3.34%-20.18%+24.27%GBCSSelectis Health0.00%0.00%-31.36%-24.50%-39.60%RMCORoyalty Management+0.43%-1.28%-5.33%+5.00%+15.50%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationADGMAdagio MedicalN/AN/AN/AN/AN/AN/AN/AN/ACOHNCohen & Company Inc.3.7228 of 5 stars0.05.02.50.02.23.31.9GBCSSelectis HealthN/AN/AN/AN/AN/AN/AN/AN/ARMCORoyalty Management0.8651 of 5 stars0.05.00.00.00.03.30.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceADGMAdagio Medical 0.00N/AN/AN/ACOHNCohen & Company Inc. 0.00N/AN/AN/AGBCSSelectis Health 0.00N/AN/AN/ARMCORoyalty Management 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookADGMAdagio Medical$266K68.81N/AN/A($3.49) per share-0.34COHNCohen & Company Inc.$82.98M0.19N/AN/A$50.39 per share0.16GBCSSelectis Health$36.78M0.13N/AN/A($1.22) per share-1.24RMCORoyalty Management$1.57M11.02N/AN/A$0.78 per share1.48Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateADGMAdagio Medical-$2.13MN/A0.00∞N/AN/A160.59%40.99%N/ACOHNCohen & Company Inc.-$9.19M$4.091.97∞N/A6.67%14.28%1.65%8/4/2025 (Estimated)GBCSSelectis Health-$3.97M-$0.79N/A∞N/A-14.37%N/A-14.59%N/ARMCORoyalty Management-$1.11M-$0.02N/A∞N/A-62.90%-3.72%-2.88%N/ALatest GBCS, ADGM, RMCO, and COHN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/20/2025Q1 2025GBCSSelectis HealthN/A-$0.22N/A-$0.22N/A$10.49 million5/15/2025N/AADGMAdagio MedicalN/A-$0.51N/A-$0.51N/AN/A4/15/2025Q4 2024GBCSSelectis HealthN/A-$0.19N/A-$0.19N/A$10.40 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthADGMAdagio MedicalN/AN/AN/AN/AN/ACOHNCohen & Company Inc.$1.0012.44%+25.99%24.45%N/AGBCSSelectis Health$0.042.65%N/AN/A N/ARMCORoyalty ManagementN/AN/AN/AN/AN/ALatest GBCS, ADGM, RMCO, and COHN DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/2/2025COHNCohen & Company Inc.quarterly$0.2511.7%5/16/20255/16/20256/2/20253/10/2025COHNCohen & Company Inc.quarterly$0.2511.4%3/26/20253/26/20254/9/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioADGMAdagio Medical0.184.423.90COHNCohen & Company Inc.0.351.011.01GBCSSelectis HealthN/A0.170.17RMCORoyalty ManagementN/A0.810.81Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipADGMAdagio Medical48.08%COHNCohen & Company Inc.14.26%GBCSSelectis HealthN/ARMCORoyalty Management67.15%Insider OwnershipCompanyInsider OwnershipADGMAdagio Medical53.45%COHNCohen & Company Inc.77.17%GBCSSelectis Health15.20%RMCORoyalty Management66.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableADGMAdagio Medical8715.38 million7.16 millionN/ACOHNCohen & Company Inc.1201.95 million445,000Not OptionableGBCSSelectis Health5003.07 million2.60 millionNot OptionableRMCORoyalty ManagementN/A14.96 million4.97 millionN/AGBCS, ADGM, RMCO, and COHN HeadlinesRecent News About These CompaniesEQS-News: Royalty Management Holding Corporation Affirms Commencement of Regular Quarterly Cash Dividend to ShareholdersMay 23 at 11:13 AM | finanzen.atRoyalty Management Holding Corporation Affirms Commencement of Regular Quarterly Cash Dividend to ShareholdersMay 23 at 11:13 AM | finance.yahoo.comRoyalty Management Holding Corporation Provides Funds for Additional Development and Mineral Analysis at Its Jamaican Critical Mineral InvestmentApril 25, 2025 | finance.yahoo.comRoyalty Management Holding Corporation Provides Update on Its Portfolio and Investment Alignment With US Critical Mineral StrategyApril 22, 2025 | finance.yahoo.comEQS-News: Royalty Management Holding Corporation Provides Update on Its Portfolio and Investment Alignment With US Critical Mineral StrategyApril 21, 2025 | markets.businessinsider.comRoyalty Management Holding Corporation Pre-Announces Record Breaking First Quarter 2025 Revenues of Approximately $973,000April 14, 2025 | finance.yahoo.comEQS-News: Royalty Management Holding Corporation Pre-Announces Record Breaking First Quarter 2025 Revenues of Approximately $973,000April 14, 2025 | markets.businessinsider.comRoyalty Management Holding Corporation Reports 2024 Financial Results, Including Positive Cashflow From Operations of $646,290 For Full YearMarch 31, 2025 | finance.yahoo.comEQS-News: Royalty Management Holding Corporation Applauds Critical Mineral Executive Order Signed by President of the United StatesMarch 21, 2025 | markets.businessinsider.comRoyalty Management Holding Corporation Applauds Critical Mineral Executive Order Signed by President of the United StatesMarch 21, 2025 | finance.yahoo.comRoyalty Management Holding Corporation Partners on Chilean Heavy Rare Earth MineMarch 17, 2025 | finance.yahoo.comEQS-News: Royalty Management Holding Corporation Partners on Chilean Heavy Rare Earth MineMarch 17, 2025 | markets.businessinsider.comEQS-News: Royalty Management Holding Corporation Expands Holdings In Alternative Currency Marketplace With Investment Strategy in SOL.X and LBX.XFebruary 24, 2025 | markets.businessinsider.comRoyalty Management Holding Corp Declares Commencement of Regular Quarterly Cash Dividend to ShareholdersJanuary 30, 2025 | finance.yahoo.comRoyalty Management Holding Corp Provides Year in Review and Preannounces Estimated Revenue Growth of Over 50%, Year-Over-YearJanuary 16, 2025 | finance.yahoo.comEQS-News: Royalty Management Holding Corp Provides Year in Review and Preannounces Estimated Revenue Growth of Over 50%, Year-Over-YearJanuary 16, 2025 | markets.businessinsider.comRoyalty Management Holding Corporation Completes Private Purchase of Company StockJanuary 13, 2025 | finance.yahoo.comRoyalty Pharma Announces Transformative Step in Company’s Evolution With Acquisition of its External Manager and $3 Billion Share Repurchase ProgramJanuary 10, 2025 | markets.businessinsider.comRoyalty Pharma to Simplify Corporate Structure in $1.1B Deal for External ManagerJanuary 10, 2025 | marketwatch.comJanuary 2025 Update Letter to ShareholdersJanuary 8, 2025 | accesswire.comMedia Sentiment Over TimeGBCS, ADGM, RMCO, and COHN Company DescriptionsAdagio Medical NASDAQ:ADGM$1.19 +0.04 (+3.48%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$1.14 -0.05 (-4.12%) As of 05/23/2025 04:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. The company is based in Laguna Hills, California.Cohen & Company Inc. NYSEAMERICAN:COHN$8.04 -0.08 (-0.99%) Closing price 05/23/2025 04:10 PM EasternExtended Trading$7.96 -0.08 (-1.00%) As of 05/23/2025 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cohen & Co., Inc. engages in fixed income markets. It operates through the following segments: Capital Markets, Asset Management, and Principal Investing. The Capital Markets segment consists of fixed income sales, trading, matched book repo financing, and new issue placements in corporate and securitized products and advisory services, operating primarily through its subsidiaries. The Asset Management segment manages assets through investment vehicles, such as collateralized debt obligations, managed accounts, and investment funds. The Principal Investing segment includes investments that made for the purpose of earning an investment return. The company was founded in 1999 and is headquartered in Philadelphia, PA.Selectis Health OTCMKTS:GBCS$1.51 0.00 (0.00%) As of 05/22/2025Selectis Health owns and/or operates healthcare facilities in Arkansas, Georgia, Ohio, and Oklahoma, providing a wide array of living services, speech, occupational, physical therapies, social services, and other rehabilitation and healthcare services. Selectis focuses on building strategic relationships with local communities in which its partnership can improve the quality of care for facility residents. With its focused growth strategy, Selectis intends to deepen its American Southcentral and Southeastern market presence to better serve the aging population along a full continuum of care.Royalty Management NASDAQ:RMCO$1.16 +0.01 (+0.87%) As of 05/23/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Royalty Management Holding Corporation provides environmental consulting and services in the United States. It is also involved in investing or purchasing assets, such as real estate and mining permits, patents, intellectual property, and emerging technologies. The company was incorporated in 2021 and is based in Fishers, Indiana. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Turbulence for Joby Shares: What's Behind the Recent Dip? Pfizer's 7.5% Dividend: Income Haven or House of Cards? TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain Advance Auto Parts Jumps on Surprise Earnings Beat Costco Stock at $1K: Dominance or Danger Zone? Williams-Sonoma: A Fundamentally Good Buy On Sale Now Snowflake Breaks Out! Can It Drift Higher in 2025 and Beyond? Alphabet Gets JPMorgan’s Vote of Confidence After Google I/O Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
